246 related articles for article (PubMed ID: 19910905)
1. Targeted therapy in radioiodine refractory thyroid cancer.
Pacini F; Brilli L; Marchisotta S
Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
[TBL] [Abstract][Full Text] [Related]
2. New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
Capdevila J; Argiles G; Rodriguez-Frexinos V; Nuñez I; Tabernero J
Discov Med; 2010 Feb; 9(45):153-62. PubMed ID: 20193642
[TBL] [Abstract][Full Text] [Related]
3. Update on thyroid cancer treatment.
Regalbuto C; Frasca F; Pellegriti G; Malandrino P; Marturano I; Di Carlo I; Pezzino V
Future Oncol; 2012 Oct; 8(10):1331-48. PubMed ID: 23130931
[TBL] [Abstract][Full Text] [Related]
4. New molecular targeted therapies in thyroid cancer.
Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy for thyroid cancer: An updated review of investigational agents.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
[TBL] [Abstract][Full Text] [Related]
6. Target therapies for radioiodine refractory advanced thyroid tumors.
Schlumberger M
J Endocrinol Invest; 2012; 35(6 Suppl):40-4. PubMed ID: 23014073
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeted therapies for patients with refractory thyroid cancer.
Chougnet C; Brassard M; Leboulleux S; Baudin E; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):448-55. PubMed ID: 20554167
[TBL] [Abstract][Full Text] [Related]
8. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research.
Sarlis NJ
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):103-15. PubMed ID: 12476792
[TBL] [Abstract][Full Text] [Related]
9. Redifferentiating agents in non-radioiodine avid cancer.
Seregni E; Vellani C; Castellani MR; Maccauro M; Pallotti F; Scaramellini G; Guzzo M; Greco A
Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):513-9. PubMed ID: 19910904
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ
Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
[TBL] [Abstract][Full Text] [Related]
11. Update on recent developments in the therapy of differentiated thyroid cancer.
Middendorp M; Grünwald F
Semin Nucl Med; 2010 Mar; 40(2):145-52. PubMed ID: 20113682
[TBL] [Abstract][Full Text] [Related]
12. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Oncol; 2008 Jan; 20(1):19-24. PubMed ID: 18043252
[TBL] [Abstract][Full Text] [Related]
13. Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets.
Spitzweg C; Bible KC; Hofbauer LC; Morris JC
Lancet Diabetes Endocrinol; 2014 Oct; 2(10):830-42. PubMed ID: 24898835
[TBL] [Abstract][Full Text] [Related]
14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies].
Malouf G; Baudin E; Soria JC; Schlumberger M
Bull Cancer; 2009 Jan; 96(1):95-101. PubMed ID: 19211364
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy of thyroid cancer.
Sherman SI
Biochem Pharmacol; 2010 Sep; 80(5):592-601. PubMed ID: 20471374
[TBL] [Abstract][Full Text] [Related]
17. Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma.
Zanotti-Fregonara P; Hindié E; Faugeron I; Moretti JL; Ravasi L; Rubello D; Toubert ME
Minerva Endocrinol; 2008 Dec; 33(4):313-27. PubMed ID: 18923368
[TBL] [Abstract][Full Text] [Related]
18. New targets and therapeutic approaches for endocrine malignancies.
Fassnacht M; Kreissl MC; Weismann D; Allolio B
Pharmacol Ther; 2009 Jul; 123(1):117-41. PubMed ID: 19374919
[TBL] [Abstract][Full Text] [Related]
19. Emerging molecular therapies of advanced thyroid cancer.
Catalano MG; Poli R; Pugliese M; Fortunati N; Boccuzzi G
Mol Aspects Med; 2010 Apr; 31(2):215-26. PubMed ID: 20176050
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis.
Shen CT; Qiu ZL; Luo QY
Endocr Relat Cancer; 2014 Apr; 21(2):253-61. PubMed ID: 24302666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
